Hudson Bay Capital Management’s Edwards Lifesciences EW Stock Holding History

Hudson Bay Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.06M	Sell	89,100 -443,000	-83%	-$37.1M	0.02%	419
2026 Q1	$42.6M	Sell	532,100 -129,500	-20%	-$10.7M	0.15%	118
2025 Q4	$56.4M	Sell	661,600 -271,120	-29%	-$22.2M	0.19%	100
2025 Q3	$72.5M	Sell	932,720 -1,729	-0.2%	-$135K	0.24%	71
2025 Q2	$73.1M	Buy	+934,449	New	+$69.7M	0.25%	78
2018 Q2	–	Sell	-10,200	Closed	-$474K	–	847
2018 Q1	$474K	Buy	+10,200	New	+$443K	0.01%	675

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Hudson Bay Capital Management's EW Position: Q2 2026 in Review

Hudson Bay Capital Management reduced its Edwards Lifesciences (EW) stake by 83% in Q2 2026, selling an estimated $37.1M and leaving 89,100 shares worth $8.06M. The position accounts for 0.02% of the portfolio, ranked #419.

Hudson Bay Capital Management first reported a position in EW in Q1 2018 and has held it in 6 quarters since. The position peaked at $73.1M in Q2 2025. 1,337 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Hudson Bay Capital Management held 89,100 shares of Edwards Lifesciences worth $8.06M as of Q2 2026.
Hudson Bay Capital Management sold 443,000 Edwards Lifesciences shares in Q2 2026, an estimated $37.1M.
Edwards Lifesciences made up 0.02% of Hudson Bay Capital Management's portfolio in Q2 2026, its #419 holding.
Hudson Bay Capital Management first reported a position in Edwards Lifesciences in Q1 2018 and has held it in 6 quarters since.
Hudson Bay Capital Management's Edwards Lifesciences position peaked at $73.1M in Q2 2025.
1,337 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.